Pharmacologically, KLOW is mostly given as small subcutaneous injections in research studies, with typical vials containing 50 to 100 milligrams, split into daily or every-other-day doses over 410 week cycles
Similarly, earlier studies led by Sikiric and colleagues in the 1990s suggested safety and benefit in gastrointestinal conditions such as ulcerative colitis, but these reports were published only in abstracts or local conference proceedings, with no independent replication or peer-reviewed validation
Koppula, P., Zhang, Y., Shi, J., Li, W
It was discovered in 1905 in Liebigs meat extracts, a popular dietary supplement at that time, by Gulewitsch and Krimberg [1] who named the substance from the Latin word for flesh (carnus)
Impurities can include failed synthesis sequences or leftover chemical reagents, which can cause adverse reactions or render the peptide inert
guaranteed satisfactio